Possible side effects of GLP-1s (Wegovy, Saxenda, Zepbound) Side effects tend to be focused on the gastrointestinal system, where these medications work by changing gut hormones
Further analyses of differentially expressed genes between GLP-1MK-801 and semaglutide treatment groups support this notion by showing enrichment of functional terms pertaining to glutamatergic signalling and synaptic plasticity among the most upregulated genes
A major side effect of this class of drugs is rapid weight loss
The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses
These findings underscore that GLP-1 therapy is a long-term intervention rather than a short-term solution
The samples were processed by pretreatment with 6 M urea for 30 min at 0 C followed by 20% trichloroacetic acid in acetone (wt./v%) at 20 C overnight